DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs

DURECT Corp (DRRX) Tops Q2 EPS by 7c

August 3, 2020 4:52 PM EDT

DURECT Corp (NASDAQ: DRRX) reported Q2 EPS of $0.07, $0.07 better than the analyst estimate of $0.00. Revenue for the quarter came in at $25.8 million versus the consensus estimate of $11.48 million.

"We continued to make progress in our clinical programs investigating DUR-928, our lead epigenetic... More